Mondinedo, Neña Lyn M.
HRN: 21-59-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2022
CEFUROXIME 500MG (TAB)
07/15/2022
07/22/2022
ORAL
500mg
BID
PROM
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes